New York, NY, United States of America

John Desmond Finan

This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Desmond Finan. Retrieved from https://idiyas.com/inventor/john-desmond-finan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Desmond Finan: Inventor in Brain Tissue Swelling Research.

Introduction

John Desmond Finan is an inventor associated with Columbia University in New York, NY (US). His patent work addresses a potential approach to reducing brain tissue swelling and managing edema.

Latest Patents

Finan is associated with 1 patent, titled “Enzyme Combinations to Reduce Brain Tissue Swelling.” The invention identifies tissue fixed charge density (FCD) as a potential therapeutic target. It describes how reducing FCD may lessen the thermodynamic force that drives water into brain tissue. The patent further reports that chondroitinase ABC (ChABC) reduces tissue FCD and swelling, suggesting a possible treatment for edema and a means of controlling intracranial pressure.

Career Highlights

Finan’s listed invention connects research into brain tissue properties with a potential therapeutic strategy. His work is associated with Columbia University.

Collaborations

Finan’s named coworkers include Benjamin Simon Elkin and Barclay Morrison III.

Conclusion

John Desmond Finan’s patent describes an enzyme-based approach that may reduce brain tissue swelling by targeting fixed charge density, with potential relevance to edema treatment and intracranial pressure control.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…